Avastin has been approved as a colon cancer and lung cancer drug. However, Avastin has been used off-label to treat other cancers and macular degeneration. The off-label use of Avastin to treat … [Read more...]
Off-Label Avastin for Wet Macular Degeneration – The Debate Continues
Off-Label Avastin Treatment for Macular Degeneration
Avastin, or bevacizumab, has become a popular off-label treatment for wet macular degeneration. Approved as a colon cancer drug, Avastin has shown to be as effective a treatment for macular … [Read more...]
British Parliament Responds to Macular Degeneration Petition
The British Parliament was presented with a petition from Macular Degeneration Patients stating "We the undersigned petition the Prime Minister to authorise use of all available drugs to combat … [Read more...]
Avastin for Wet Macular Degeneration – Off Label Usage
Avastin (bevacizumab) has become a drug of choice by some opthalmologists for a treatment of wet macular degeneration. Genetech, the company that produces Avastin, would prefer that Lucentis be used … [Read more...]



Recent Comments